These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8093146)

  • 1. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
    Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
    O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
    Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocytosis of donor origin in cerebrospinal fluid, and marrow aplasia after donor leukocyte infusion for EBV-lymphoproliferative disease.
    Gharpure V; Rubin L; Amlin J; Emanuel D; Schroeder W; Davidson A; Hromas R; Cornetta K
    Bone Marrow Transplant; 1996 Jul; 18(1):221-4. PubMed ID: 8832021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of EBV-infected cells in donor marrow by counterflow elutriation.
    Gross TG; Hinrichs SH; Davis JR; Mitchell D; Bishop MR; Wagner JE
    Exp Hematol; 1998 May; 26(5):395-9. PubMed ID: 9590655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
    Lucas KG; Salzman D; Garcia A; Sun Q
    Cancer; 2004 May; 100(9):1892-901. PubMed ID: 15112270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH; Chiang KY; McGuirk JP; Pati AR; Godder KT; Welsh JA; Waldron RL; McElveen JL; Henslee-Downey PJ
    Bone Marrow Transplant; 1998 Feb; 21(3):295-7. PubMed ID: 9489654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using T cells to treat B-cell cancers.
    Lieberman J; Buchsbaum RJ
    N Engl J Med; 1994 Apr; 330(17):1231-3. PubMed ID: 8139635
    [No Abstract]   [Full Text] [Related]  

  • 17. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?
    Mackinnon S; Papadopoulos EB; Carabasi MH; Reich L; Collins NH; O'Reilly RJ
    Bone Marrow Transplant; 1995 Apr; 15(4):591-4. PubMed ID: 7655386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes.
    Hong R; Shen V; Rooney C; Hughes DP; Smith C; Comoli P; Zhang L
    Clin Immunol; 2001 Jan; 98(1):54-61. PubMed ID: 11141327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
    Shearer WT; Ritz J; Finegold MJ; Guerra IC; Rosenblatt HM; Lewis DE; Pollack MS; Taber LH; Sumaya CV; Grumet FC
    N Engl J Med; 1985 May; 312(18):1151-9. PubMed ID: 2984567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.